U.S. COMPANY FILING
BOSTON SCIENTIFIC CORP — Form 10-Q filed 2026-05-01
Filing text preview
Boston Scientific reported Q1 2026 net sales of $5.203 billion, up 11.6% year-over-year, with organic growth of 9.4%. Net income attributable to common stockholders surged 98.8% to $1.341 billion. The company completed the acquisition of Nalu Medical and increased its stock repurchase authorization by $4 billion to $5 billion. Both MedSurg and Cardiovascular segments contributed to growth.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record